Mumps Vaccine Market, Global Outlook and Forecast 2022-2028
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
This report contains market size and forecasts of Mumps Vaccine in global, including the following market information:
Global Mumps Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mumps Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Mumps Vaccine companies in 2021 (%)
The global Mumps Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Child Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mumps Vaccine include MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited and Emergent BioSolutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mumps Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mumps Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mumps Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Mumps Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Mumps Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Mumps Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mumps Vaccine revenues share in global market, 2021 (%)
Key companies Mumps Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Mumps Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Mumps Vaccine in global, including the following market information:
Global Mumps Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mumps Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Mumps Vaccine companies in 2021 (%)
The global Mumps Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Child Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mumps Vaccine include MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited and Emergent BioSolutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mumps Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mumps Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mumps Vaccine Market Segment Percentages, by Type, 2021 (%)
- Child
- Adult
Global Mumps Vaccine Market Segment Percentages, by Application, 2021 (%)
- Hospitals Pharmacies
- Retail Pharmacies
Global Mumps Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Mumps Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mumps Vaccine revenues share in global market, 2021 (%)
Key companies Mumps Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Mumps Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- MedImmune
- Johnson & Johnson
- Merck & Co., Inc.
- Sanofi
- Serum Institute of India
- Bavarian Nordic
- Astellas Pharma India
- CSL Limited
- Emergent BioSolutions
- GlaxoSmithKline
- Panacea Biotec, Ltd.
- Biological E Limited
- Bharat Biotech Ltd.
- Novavax, Inc.
- Novartis
- Sinovac Biotech, Ltd.
- Incepta Vaccine Limited
- Valneva SE
- VBI Vaccines
- PT Bio Farma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Mumps Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mumps Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MUMPS VACCINE OVERALL MARKET SIZE
2.1 Global Mumps Vaccine Market Size: 2021 VS 2028
2.2 Global Mumps Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Mumps Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Mumps Vaccine Players in Global Market
3.2 Top Global Mumps Vaccine Companies Ranked by Revenue
3.3 Global Mumps Vaccine Revenue by Companies
3.4 Global Mumps Vaccine Sales by Companies
3.5 Global Mumps Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Mumps Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Mumps Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mumps Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Mumps Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Mumps Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Mumps Vaccine Market Size Markets, 2021 & 2028
4.1.2 Child
4.1.3 Adult
4.2 By Type - Global Mumps Vaccine Revenue & Forecasts
4.2.1 By Type - Global Mumps Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Mumps Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Mumps Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Mumps Vaccine Sales & Forecasts
4.3.1 By Type - Global Mumps Vaccine Sales, 2017-2022
4.3.2 By Type - Global Mumps Vaccine Sales, 2023-2028
4.3.3 By Type - Global Mumps Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Mumps Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Mumps Vaccine Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.2 By Application - Global Mumps Vaccine Revenue & Forecasts
5.2.1 By Application - Global Mumps Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Mumps Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Mumps Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Mumps Vaccine Sales & Forecasts
5.3.1 By Application - Global Mumps Vaccine Sales, 2017-2022
5.3.2 By Application - Global Mumps Vaccine Sales, 2023-2028
5.3.3 By Application - Global Mumps Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Mumps Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Mumps Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Mumps Vaccine Revenue & Forecasts
6.2.1 By Region - Global Mumps Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Mumps Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Mumps Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Mumps Vaccine Sales & Forecasts
6.3.1 By Region - Global Mumps Vaccine Sales, 2017-2022
6.3.2 By Region - Global Mumps Vaccine Sales, 2023-2028
6.3.3 By Region - Global Mumps Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Mumps Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Mumps Vaccine Sales, 2017-2028
6.4.3 US Mumps Vaccine Market Size, 2017-2028
6.4.4 Canada Mumps Vaccine Market Size, 2017-2028
6.4.5 Mexico Mumps Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Mumps Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Mumps Vaccine Sales, 2017-2028
6.5.3 Germany Mumps Vaccine Market Size, 2017-2028
6.5.4 France Mumps Vaccine Market Size, 2017-2028
6.5.5 U.K. Mumps Vaccine Market Size, 2017-2028
6.5.6 Italy Mumps Vaccine Market Size, 2017-2028
6.5.7 Russia Mumps Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Mumps Vaccine Market Size, 2017-2028
6.5.9 Benelux Mumps Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Mumps Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Mumps Vaccine Sales, 2017-2028
6.6.3 China Mumps Vaccine Market Size, 2017-2028
6.6.4 Japan Mumps Vaccine Market Size, 2017-2028
6.6.5 South Korea Mumps Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Mumps Vaccine Market Size, 2017-2028
6.6.7 India Mumps Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Mumps Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Mumps Vaccine Sales, 2017-2028
6.7.3 Brazil Mumps Vaccine Market Size, 2017-2028
6.7.4 Argentina Mumps Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Mumps Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Mumps Vaccine Sales, 2017-2028
6.8.3 Turkey Mumps Vaccine Market Size, 2017-2028
6.8.4 Israel Mumps Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Mumps Vaccine Market Size, 2017-2028
6.8.6 UAE Mumps Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 MedImmune
7.1.1 MedImmune Corporate Summary
7.1.2 MedImmune Business Overview
7.1.3 MedImmune Mumps Vaccine Major Product Offerings
7.1.4 MedImmune Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 MedImmune Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Mumps Vaccine Major Product Offerings
7.2.4 Johnson & Johnson Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Corporate Summary
7.3.2 Merck & Co., Inc. Business Overview
7.3.3 Merck & Co., Inc. Mumps Vaccine Major Product Offerings
7.3.4 Merck & Co., Inc. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Merck & Co., Inc. Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Mumps Vaccine Major Product Offerings
7.4.4 Sanofi Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Serum Institute of India
7.5.1 Serum Institute of India Corporate Summary
7.5.2 Serum Institute of India Business Overview
7.5.3 Serum Institute of India Mumps Vaccine Major Product Offerings
7.5.4 Serum Institute of India Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Serum Institute of India Key News
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Corporate Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Mumps Vaccine Major Product Offerings
7.6.4 Bavarian Nordic Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Bavarian Nordic Key News
7.7 Astellas Pharma India
7.7.1 Astellas Pharma India Corporate Summary
7.7.2 Astellas Pharma India Business Overview
7.7.3 Astellas Pharma India Mumps Vaccine Major Product Offerings
7.7.4 Astellas Pharma India Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharma India Key News
7.8 CSL Limited
7.8.1 CSL Limited Corporate Summary
7.8.2 CSL Limited Business Overview
7.8.3 CSL Limited Mumps Vaccine Major Product Offerings
7.8.4 CSL Limited Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 CSL Limited Key News
7.9 Emergent BioSolutions
7.9.1 Emergent BioSolutions Corporate Summary
7.9.2 Emergent BioSolutions Business Overview
7.9.3 Emergent BioSolutions Mumps Vaccine Major Product Offerings
7.9.4 Emergent BioSolutions Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Emergent BioSolutions Key News
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Corporate Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Mumps Vaccine Major Product Offerings
7.10.4 GlaxoSmithKline Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 GlaxoSmithKline Key News
7.11 Panacea Biotec, Ltd.
7.11.1 Panacea Biotec, Ltd. Corporate Summary
7.11.2 Panacea Biotec, Ltd. Mumps Vaccine Business Overview
7.11.3 Panacea Biotec, Ltd. Mumps Vaccine Major Product Offerings
7.11.4 Panacea Biotec, Ltd. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 Panacea Biotec, Ltd. Key News
7.12 Biological E Limited
7.12.1 Biological E Limited Corporate Summary
7.12.2 Biological E Limited Mumps Vaccine Business Overview
7.12.3 Biological E Limited Mumps Vaccine Major Product Offerings
7.12.4 Biological E Limited Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Biological E Limited Key News
7.13 Bharat Biotech Ltd.
7.13.1 Bharat Biotech Ltd. Corporate Summary
7.13.2 Bharat Biotech Ltd. Mumps Vaccine Business Overview
7.13.3 Bharat Biotech Ltd. Mumps Vaccine Major Product Offerings
7.13.4 Bharat Biotech Ltd. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Bharat Biotech Ltd. Key News
7.14 Novavax, Inc.
7.14.1 Novavax, Inc. Corporate Summary
7.14.2 Novavax, Inc. Business Overview
7.14.3 Novavax, Inc. Mumps Vaccine Major Product Offerings
7.14.4 Novavax, Inc. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.14.5 Novavax, Inc. Key News
7.15 Novartis
7.15.1 Novartis Corporate Summary
7.15.2 Novartis Business Overview
7.15.3 Novartis Mumps Vaccine Major Product Offerings
7.15.4 Novartis Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.15.5 Novartis Key News
7.16 Sinovac Biotech, Ltd.
7.16.1 Sinovac Biotech, Ltd. Corporate Summary
7.16.2 Sinovac Biotech, Ltd. Business Overview
7.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Major Product Offerings
7.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.16.5 Sinovac Biotech, Ltd. Key News
7.17 Incepta Vaccine Limited
7.17.1 Incepta Vaccine Limited Corporate Summary
7.17.2 Incepta Vaccine Limited Business Overview
7.17.3 Incepta Vaccine Limited Mumps Vaccine Major Product Offerings
7.17.4 Incepta Vaccine Limited Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.17.5 Incepta Vaccine Limited Key News
7.18 Valneva SE
7.18.1 Valneva SE Corporate Summary
7.18.2 Valneva SE Business Overview
7.18.3 Valneva SE Mumps Vaccine Major Product Offerings
7.18.4 Valneva SE Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.18.5 Valneva SE Key News
7.19 VBI Vaccines
7.19.1 VBI Vaccines Corporate Summary
7.19.2 VBI Vaccines Business Overview
7.19.3 VBI Vaccines Mumps Vaccine Major Product Offerings
7.19.4 VBI Vaccines Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.19.5 VBI Vaccines Key News
7.20 PT Bio Farma
7.20.1 PT Bio Farma Corporate Summary
7.20.2 PT Bio Farma Business Overview
7.20.3 PT Bio Farma Mumps Vaccine Major Product Offerings
7.20.4 PT Bio Farma Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.20.5 PT Bio Farma Key News
8 GLOBAL MUMPS VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Mumps Vaccine Production Capacity, 2017-2028
8.2 Mumps Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Mumps Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MUMPS VACCINE SUPPLY CHAIN ANALYSIS
10.1 Mumps Vaccine Industry Value Chain
10.2 Mumps Vaccine Upstream Market
10.3 Mumps Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Mumps Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Mumps Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mumps Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MUMPS VACCINE OVERALL MARKET SIZE
2.1 Global Mumps Vaccine Market Size: 2021 VS 2028
2.2 Global Mumps Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Mumps Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Mumps Vaccine Players in Global Market
3.2 Top Global Mumps Vaccine Companies Ranked by Revenue
3.3 Global Mumps Vaccine Revenue by Companies
3.4 Global Mumps Vaccine Sales by Companies
3.5 Global Mumps Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Mumps Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Mumps Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mumps Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Mumps Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Mumps Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Mumps Vaccine Market Size Markets, 2021 & 2028
4.1.2 Child
4.1.3 Adult
4.2 By Type - Global Mumps Vaccine Revenue & Forecasts
4.2.1 By Type - Global Mumps Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Mumps Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Mumps Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Mumps Vaccine Sales & Forecasts
4.3.1 By Type - Global Mumps Vaccine Sales, 2017-2022
4.3.2 By Type - Global Mumps Vaccine Sales, 2023-2028
4.3.3 By Type - Global Mumps Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Mumps Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Mumps Vaccine Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.2 By Application - Global Mumps Vaccine Revenue & Forecasts
5.2.1 By Application - Global Mumps Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Mumps Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Mumps Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Mumps Vaccine Sales & Forecasts
5.3.1 By Application - Global Mumps Vaccine Sales, 2017-2022
5.3.2 By Application - Global Mumps Vaccine Sales, 2023-2028
5.3.3 By Application - Global Mumps Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Mumps Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Mumps Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Mumps Vaccine Revenue & Forecasts
6.2.1 By Region - Global Mumps Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Mumps Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Mumps Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Mumps Vaccine Sales & Forecasts
6.3.1 By Region - Global Mumps Vaccine Sales, 2017-2022
6.3.2 By Region - Global Mumps Vaccine Sales, 2023-2028
6.3.3 By Region - Global Mumps Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Mumps Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Mumps Vaccine Sales, 2017-2028
6.4.3 US Mumps Vaccine Market Size, 2017-2028
6.4.4 Canada Mumps Vaccine Market Size, 2017-2028
6.4.5 Mexico Mumps Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Mumps Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Mumps Vaccine Sales, 2017-2028
6.5.3 Germany Mumps Vaccine Market Size, 2017-2028
6.5.4 France Mumps Vaccine Market Size, 2017-2028
6.5.5 U.K. Mumps Vaccine Market Size, 2017-2028
6.5.6 Italy Mumps Vaccine Market Size, 2017-2028
6.5.7 Russia Mumps Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Mumps Vaccine Market Size, 2017-2028
6.5.9 Benelux Mumps Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Mumps Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Mumps Vaccine Sales, 2017-2028
6.6.3 China Mumps Vaccine Market Size, 2017-2028
6.6.4 Japan Mumps Vaccine Market Size, 2017-2028
6.6.5 South Korea Mumps Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Mumps Vaccine Market Size, 2017-2028
6.6.7 India Mumps Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Mumps Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Mumps Vaccine Sales, 2017-2028
6.7.3 Brazil Mumps Vaccine Market Size, 2017-2028
6.7.4 Argentina Mumps Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Mumps Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Mumps Vaccine Sales, 2017-2028
6.8.3 Turkey Mumps Vaccine Market Size, 2017-2028
6.8.4 Israel Mumps Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Mumps Vaccine Market Size, 2017-2028
6.8.6 UAE Mumps Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 MedImmune
7.1.1 MedImmune Corporate Summary
7.1.2 MedImmune Business Overview
7.1.3 MedImmune Mumps Vaccine Major Product Offerings
7.1.4 MedImmune Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 MedImmune Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Mumps Vaccine Major Product Offerings
7.2.4 Johnson & Johnson Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Corporate Summary
7.3.2 Merck & Co., Inc. Business Overview
7.3.3 Merck & Co., Inc. Mumps Vaccine Major Product Offerings
7.3.4 Merck & Co., Inc. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Merck & Co., Inc. Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Mumps Vaccine Major Product Offerings
7.4.4 Sanofi Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Serum Institute of India
7.5.1 Serum Institute of India Corporate Summary
7.5.2 Serum Institute of India Business Overview
7.5.3 Serum Institute of India Mumps Vaccine Major Product Offerings
7.5.4 Serum Institute of India Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Serum Institute of India Key News
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Corporate Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Mumps Vaccine Major Product Offerings
7.6.4 Bavarian Nordic Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Bavarian Nordic Key News
7.7 Astellas Pharma India
7.7.1 Astellas Pharma India Corporate Summary
7.7.2 Astellas Pharma India Business Overview
7.7.3 Astellas Pharma India Mumps Vaccine Major Product Offerings
7.7.4 Astellas Pharma India Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharma India Key News
7.8 CSL Limited
7.8.1 CSL Limited Corporate Summary
7.8.2 CSL Limited Business Overview
7.8.3 CSL Limited Mumps Vaccine Major Product Offerings
7.8.4 CSL Limited Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 CSL Limited Key News
7.9 Emergent BioSolutions
7.9.1 Emergent BioSolutions Corporate Summary
7.9.2 Emergent BioSolutions Business Overview
7.9.3 Emergent BioSolutions Mumps Vaccine Major Product Offerings
7.9.4 Emergent BioSolutions Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Emergent BioSolutions Key News
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Corporate Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Mumps Vaccine Major Product Offerings
7.10.4 GlaxoSmithKline Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 GlaxoSmithKline Key News
7.11 Panacea Biotec, Ltd.
7.11.1 Panacea Biotec, Ltd. Corporate Summary
7.11.2 Panacea Biotec, Ltd. Mumps Vaccine Business Overview
7.11.3 Panacea Biotec, Ltd. Mumps Vaccine Major Product Offerings
7.11.4 Panacea Biotec, Ltd. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 Panacea Biotec, Ltd. Key News
7.12 Biological E Limited
7.12.1 Biological E Limited Corporate Summary
7.12.2 Biological E Limited Mumps Vaccine Business Overview
7.12.3 Biological E Limited Mumps Vaccine Major Product Offerings
7.12.4 Biological E Limited Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Biological E Limited Key News
7.13 Bharat Biotech Ltd.
7.13.1 Bharat Biotech Ltd. Corporate Summary
7.13.2 Bharat Biotech Ltd. Mumps Vaccine Business Overview
7.13.3 Bharat Biotech Ltd. Mumps Vaccine Major Product Offerings
7.13.4 Bharat Biotech Ltd. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Bharat Biotech Ltd. Key News
7.14 Novavax, Inc.
7.14.1 Novavax, Inc. Corporate Summary
7.14.2 Novavax, Inc. Business Overview
7.14.3 Novavax, Inc. Mumps Vaccine Major Product Offerings
7.14.4 Novavax, Inc. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.14.5 Novavax, Inc. Key News
7.15 Novartis
7.15.1 Novartis Corporate Summary
7.15.2 Novartis Business Overview
7.15.3 Novartis Mumps Vaccine Major Product Offerings
7.15.4 Novartis Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.15.5 Novartis Key News
7.16 Sinovac Biotech, Ltd.
7.16.1 Sinovac Biotech, Ltd. Corporate Summary
7.16.2 Sinovac Biotech, Ltd. Business Overview
7.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Major Product Offerings
7.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.16.5 Sinovac Biotech, Ltd. Key News
7.17 Incepta Vaccine Limited
7.17.1 Incepta Vaccine Limited Corporate Summary
7.17.2 Incepta Vaccine Limited Business Overview
7.17.3 Incepta Vaccine Limited Mumps Vaccine Major Product Offerings
7.17.4 Incepta Vaccine Limited Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.17.5 Incepta Vaccine Limited Key News
7.18 Valneva SE
7.18.1 Valneva SE Corporate Summary
7.18.2 Valneva SE Business Overview
7.18.3 Valneva SE Mumps Vaccine Major Product Offerings
7.18.4 Valneva SE Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.18.5 Valneva SE Key News
7.19 VBI Vaccines
7.19.1 VBI Vaccines Corporate Summary
7.19.2 VBI Vaccines Business Overview
7.19.3 VBI Vaccines Mumps Vaccine Major Product Offerings
7.19.4 VBI Vaccines Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.19.5 VBI Vaccines Key News
7.20 PT Bio Farma
7.20.1 PT Bio Farma Corporate Summary
7.20.2 PT Bio Farma Business Overview
7.20.3 PT Bio Farma Mumps Vaccine Major Product Offerings
7.20.4 PT Bio Farma Mumps Vaccine Sales and Revenue in Global (2017-2022)
7.20.5 PT Bio Farma Key News
8 GLOBAL MUMPS VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Mumps Vaccine Production Capacity, 2017-2028
8.2 Mumps Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Mumps Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MUMPS VACCINE SUPPLY CHAIN ANALYSIS
10.1 Mumps Vaccine Industry Value Chain
10.2 Mumps Vaccine Upstream Market
10.3 Mumps Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Mumps Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Mumps Vaccine in Global Market
Table 2. Top Mumps Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Mumps Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Mumps Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Mumps Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Mumps Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Mumps Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Mumps Vaccine Product Type
Table 9. List of Global Tier 1 Mumps Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mumps Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mumps Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Mumps Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Mumps Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Mumps Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Mumps Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Mumps Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Mumps Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Mumps Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Mumps Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Mumps Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Mumps Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Mumps Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Mumps Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Mumps Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Mumps Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Mumps Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Mumps Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Mumps Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Mumps Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Mumps Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Mumps Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Mumps Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Mumps Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Mumps Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Mumps Vaccine Sales, (K Units), 2023-2028
Table 46. MedImmune Corporate Summary
Table 47. MedImmune Mumps Vaccine Product Offerings
Table 48. MedImmune Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Mumps Vaccine Product Offerings
Table 51. Johnson & Johnson Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck & Co., Inc. Corporate Summary
Table 53. Merck & Co., Inc. Mumps Vaccine Product Offerings
Table 54. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Mumps Vaccine Product Offerings
Table 57. Sanofi Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Serum Institute of India Corporate Summary
Table 59. Serum Institute of India Mumps Vaccine Product Offerings
Table 60. Serum Institute of India Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Bavarian Nordic Corporate Summary
Table 62. Bavarian Nordic Mumps Vaccine Product Offerings
Table 63. Bavarian Nordic Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Astellas Pharma India Corporate Summary
Table 65. Astellas Pharma India Mumps Vaccine Product Offerings
Table 66. Astellas Pharma India Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. CSL Limited Corporate Summary
Table 68. CSL Limited Mumps Vaccine Product Offerings
Table 69. CSL Limited Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Emergent BioSolutions Corporate Summary
Table 71. Emergent BioSolutions Mumps Vaccine Product Offerings
Table 72. Emergent BioSolutions Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. GlaxoSmithKline Corporate Summary
Table 74. GlaxoSmithKline Mumps Vaccine Product Offerings
Table 75. GlaxoSmithKline Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Panacea Biotec, Ltd. Corporate Summary
Table 77. Panacea Biotec, Ltd. Mumps Vaccine Product Offerings
Table 78. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Biological E Limited Corporate Summary
Table 80. Biological E Limited Mumps Vaccine Product Offerings
Table 81. Biological E Limited Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Bharat Biotech Ltd. Corporate Summary
Table 83. Bharat Biotech Ltd. Mumps Vaccine Product Offerings
Table 84. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Novavax, Inc. Corporate Summary
Table 86. Novavax, Inc. Mumps Vaccine Product Offerings
Table 87. Novavax, Inc. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Novartis Corporate Summary
Table 89. Novartis Mumps Vaccine Product Offerings
Table 90. Novartis Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Sinovac Biotech, Ltd. Corporate Summary
Table 92. Sinovac Biotech, Ltd. Mumps Vaccine Product Offerings
Table 93. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Incepta Vaccine Limited Corporate Summary
Table 95. Incepta Vaccine Limited Mumps Vaccine Product Offerings
Table 96. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Valneva SE Corporate Summary
Table 98. Valneva SE Mumps Vaccine Product Offerings
Table 99. Valneva SE Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. VBI Vaccines Corporate Summary
Table 101. VBI Vaccines Mumps Vaccine Product Offerings
Table 102. VBI Vaccines Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. PT Bio Farma Corporate Summary
Table 104. PT Bio Farma Mumps Vaccine Product Offerings
Table 105. PT Bio Farma Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Mumps Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 107. Global Mumps Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Mumps Vaccine Production by Region, 2017-2022 (K Units)
Table 109. Global Mumps Vaccine Production by Region, 2023-2028 (K Units)
Table 110. Mumps Vaccine Market Opportunities & Trends in Global Market
Table 111. Mumps Vaccine Market Drivers in Global Market
Table 112. Mumps Vaccine Market Restraints in Global Market
Table 113. Mumps Vaccine Raw Materials
Table 114. Mumps Vaccine Raw Materials Suppliers in Global Market
Table 115. Typical Mumps Vaccine Downstream
Table 116. Mumps Vaccine Downstream Clients in Global Market
Table 117. Mumps Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Mumps Vaccine in Global Market
Table 2. Top Mumps Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Mumps Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Mumps Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Mumps Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Mumps Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Mumps Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Mumps Vaccine Product Type
Table 9. List of Global Tier 1 Mumps Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mumps Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mumps Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Mumps Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Mumps Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Mumps Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Mumps Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Mumps Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Mumps Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Mumps Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Mumps Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Mumps Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Mumps Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Mumps Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Mumps Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Mumps Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Mumps Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Mumps Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Mumps Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Mumps Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Mumps Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Mumps Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Mumps Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Mumps Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Mumps Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Mumps Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Mumps Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Mumps Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Mumps Vaccine Sales, (K Units), 2023-2028
Table 46. MedImmune Corporate Summary
Table 47. MedImmune Mumps Vaccine Product Offerings
Table 48. MedImmune Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Mumps Vaccine Product Offerings
Table 51. Johnson & Johnson Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck & Co., Inc. Corporate Summary
Table 53. Merck & Co., Inc. Mumps Vaccine Product Offerings
Table 54. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Mumps Vaccine Product Offerings
Table 57. Sanofi Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Serum Institute of India Corporate Summary
Table 59. Serum Institute of India Mumps Vaccine Product Offerings
Table 60. Serum Institute of India Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Bavarian Nordic Corporate Summary
Table 62. Bavarian Nordic Mumps Vaccine Product Offerings
Table 63. Bavarian Nordic Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Astellas Pharma India Corporate Summary
Table 65. Astellas Pharma India Mumps Vaccine Product Offerings
Table 66. Astellas Pharma India Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. CSL Limited Corporate Summary
Table 68. CSL Limited Mumps Vaccine Product Offerings
Table 69. CSL Limited Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Emergent BioSolutions Corporate Summary
Table 71. Emergent BioSolutions Mumps Vaccine Product Offerings
Table 72. Emergent BioSolutions Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. GlaxoSmithKline Corporate Summary
Table 74. GlaxoSmithKline Mumps Vaccine Product Offerings
Table 75. GlaxoSmithKline Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Panacea Biotec, Ltd. Corporate Summary
Table 77. Panacea Biotec, Ltd. Mumps Vaccine Product Offerings
Table 78. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Biological E Limited Corporate Summary
Table 80. Biological E Limited Mumps Vaccine Product Offerings
Table 81. Biological E Limited Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Bharat Biotech Ltd. Corporate Summary
Table 83. Bharat Biotech Ltd. Mumps Vaccine Product Offerings
Table 84. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Novavax, Inc. Corporate Summary
Table 86. Novavax, Inc. Mumps Vaccine Product Offerings
Table 87. Novavax, Inc. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Novartis Corporate Summary
Table 89. Novartis Mumps Vaccine Product Offerings
Table 90. Novartis Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Sinovac Biotech, Ltd. Corporate Summary
Table 92. Sinovac Biotech, Ltd. Mumps Vaccine Product Offerings
Table 93. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Incepta Vaccine Limited Corporate Summary
Table 95. Incepta Vaccine Limited Mumps Vaccine Product Offerings
Table 96. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Valneva SE Corporate Summary
Table 98. Valneva SE Mumps Vaccine Product Offerings
Table 99. Valneva SE Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. VBI Vaccines Corporate Summary
Table 101. VBI Vaccines Mumps Vaccine Product Offerings
Table 102. VBI Vaccines Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. PT Bio Farma Corporate Summary
Table 104. PT Bio Farma Mumps Vaccine Product Offerings
Table 105. PT Bio Farma Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Mumps Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 107. Global Mumps Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Mumps Vaccine Production by Region, 2017-2022 (K Units)
Table 109. Global Mumps Vaccine Production by Region, 2023-2028 (K Units)
Table 110. Mumps Vaccine Market Opportunities & Trends in Global Market
Table 111. Mumps Vaccine Market Drivers in Global Market
Table 112. Mumps Vaccine Market Restraints in Global Market
Table 113. Mumps Vaccine Raw Materials
Table 114. Mumps Vaccine Raw Materials Suppliers in Global Market
Table 115. Typical Mumps Vaccine Downstream
Table 116. Mumps Vaccine Downstream Clients in Global Market
Table 117. Mumps Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Mumps Vaccine Segment by Type
Figure 2. Mumps Vaccine Segment by Application
Figure 3. Global Mumps Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mumps Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mumps Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Mumps Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Mumps Vaccine Revenue in 2021
Figure 9. By Type - Global Mumps Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Mumps Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Mumps Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Mumps Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Mumps Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Mumps Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Mumps Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Mumps Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Mumps Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Mumps Vaccine Sales Market Share, 2017-2028
Figure 19. US Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Mumps Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Mumps Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Mumps Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Mumps Vaccine Sales Market Share, 2017-2028
Figure 33. China Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Mumps Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Mumps Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Mumps Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Mumps Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Mumps Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Mumps Vaccine by Region, 2021 VS 2028
Figure 50. Mumps Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Mumps Vaccine Segment by Type
Figure 2. Mumps Vaccine Segment by Application
Figure 3. Global Mumps Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mumps Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mumps Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Mumps Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Mumps Vaccine Revenue in 2021
Figure 9. By Type - Global Mumps Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Mumps Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Mumps Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Mumps Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Mumps Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Mumps Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Mumps Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Mumps Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Mumps Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Mumps Vaccine Sales Market Share, 2017-2028
Figure 19. US Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Mumps Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Mumps Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Mumps Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Mumps Vaccine Sales Market Share, 2017-2028
Figure 33. China Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Mumps Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Mumps Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Mumps Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Mumps Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Mumps Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Mumps Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Mumps Vaccine by Region, 2021 VS 2028
Figure 50. Mumps Vaccine Industry Value Chain
Figure 51. Marketing Channels
